New hope for catching deadly pancreatic cancer sooner
NCT ID NCT03536793
Summary
This study aims to find better ways to detect pancreatic cancer at its earliest, most treatable stages. Researchers will analyze fluid from pancreatic cysts in 180 participants to measure specific molecules and genetic changes linked to cancer. The goal is to develop less invasive tests that can accurately tell if a cyst is becoming cancerous, helping doctors intervene sooner when surgery is still an option.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER OF PANCREAS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Castle Hill Hospital, Hull University Teaching Hospitals NHS Trust
RECRUITINGCottingham, Kingston Upon Hull, HU16 5JQ, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.